In a recent KPMG survey of deal-maker preference across healthcare and life sciences, late-stage assets garnered 70% of the vote, versus 55% for early-stage, highly innovative assets and 45% for agents at the commercial stage. Read more in Medical Marketing and Media:
Harvey Levin’s Post
More Relevant Posts
-
In a recent KPMG survey of deal-maker preference across healthcare and life sciences, late-stage assets garnered 70% of the vote, versus 55% for early-stage, highly innovative assets and 45% for agents at the commercial stage. Read more in Medical Marketing and Media:
How biotech companies are standing out during JPM Week
kpmg.voicestorm.com
To view or add a comment, sign in
-
In a recent KPMG survey of deal-maker preference across healthcare and life sciences, late-stage assets garnered 70% of the vote, versus 55% for early-stage, highly innovative assets and 45% for agents at the commercial stage. Read more in Medical Marketing and Media:
How biotech companies are standing out during JPM Week
To view or add a comment, sign in
-
Unlock the power of genuine HCP connections in life sciences! Join our webinar to discover how strategic engagement can transform your interactions with healthcare professionals and elevate your brand. Register today! https://bit.ly/3wjPQ6I #OneKey #OneKeyMarketingServices #HCPEngagement #LifeSciences
To view or add a comment, sign in
-
Dive into a practical journey of engaging with HCPs, leveraging deep insights and digital advancements. Discover how to engage at scale and in real time, regardless of your internal maturity level. Experience the power of inspiring emotions, shifting perspectives, and cultivating genuine relationships. Don't miss this opportunity to transform your HCP engagement and consistently deliver value. Join me and Miguel Fino at the webinar on Insights-Driven Dialogues!
Unlock the power of genuine HCP connections in life sciences! Join our webinar to discover how strategic engagement can transform your interactions with healthcare professionals and elevate your brand. Register today! https://bit.ly/3wjPQ6I #OneKey #OneKeyMarketingServices #HCPEngagement #LifeSciences
To view or add a comment, sign in
-
Searching for end to end solutions to improve the promotion of your brands? Discover how by joining this amazing and successful webinar!
Unlock the power of genuine HCP connections in life sciences! Join our webinar to discover how strategic engagement can transform your interactions with healthcare professionals and elevate your brand. Register today! https://bit.ly/3wjPQ6I #OneKey #OneKeyMarketingServices #HCPEngagement #LifeSciences
To view or add a comment, sign in
-
Our Transformative #Healthcare Markets team at Real Chemistry led by Rita Glaze-Rowe, is focused on continuously evolving hypotheses and finding insights to help our clients diagnose, understand, and plan against seismic shifts like the #GLP-1 market, because this space has far-reaching impact. The team has launched its first product helping #lifesciences leaders act with clarity in the face of the impact GLP-1s are already having. Click below to learn how to access our first report, which uncovers key driving forces in the market that many didn't see coming. #Diabetes #Obesity #WeightManagement
Exciting news!! Real Chemistry’s Transformative Healthcare Markets team has launched our first #product focused on helping life sciences leaders act with clarity in the face of the transformative impact GLP-1s are already having, not just on #obesity but the industry at large. This market is unprecedented for #healthcare, and the role of patients - and their relationship with HCPs - may be changed forever. Our first report dives into what’s driving this market - and it’s not what you may think. 😉✨ Learn more, schedule a demo, and buy the report from our website today. Message me or my colleague Shelly Cohn with questions! 📈✨ https://lnkd.in/ee3MBZNp #glp1s #healthcareinsights #marketintelligence #research #brandstrategy
To view or add a comment, sign in
-
Experienced marketing and strategy executive, with a passion for helping life sciences companies engage with other parts of the health care ecosystem
Fascinating first report from the Transformative Healthcare Markets team at Real Chemistry. Bold insights, esp. around the role of social media. And lots of actionable guidance for biopharma leaders directly or indirectly impacted by the rise of GLP1s. Check it out.
Exciting news!! Real Chemistry’s Transformative Healthcare Markets team has launched our first #product focused on helping life sciences leaders act with clarity in the face of the transformative impact GLP-1s are already having, not just on #obesity but the industry at large. This market is unprecedented for #healthcare, and the role of patients - and their relationship with HCPs - may be changed forever. Our first report dives into what’s driving this market - and it’s not what you may think. 😉✨ Learn more, schedule a demo, and buy the report from our website today. Message me or my colleague Shelly Cohn with questions! 📈✨ https://lnkd.in/ee3MBZNp #glp1s #healthcareinsights #marketintelligence #research #brandstrategy
To view or add a comment, sign in
-
It's #RadioAdvisory day! On the latest episode, Advisory Board pharmacy experts Rachael Peroutky, MSPH and Chloe Bakst join Rachel Woods to discuss how the industry should be thinking about this new era of drugs, and why healthcare organizations can't afford to sit around and strategize later. Listen now 🎧 http://spr.ly/6042u4yQi
Radio Advisory | Listen wherever podcasts are available
link.chtbl.com
To view or add a comment, sign in
-
Clinical Research Collaborator | Founder @TrialTalksInc | Host of @TrialTalksIncPodcast 🎙️ | Driving Patient-Centric Clinical Trials & Industry Excellence
🌟 The Unique World of Clinical Trials: How It Stands Apart From Other Industries🌟 The clinical trial industry is not just another sector; it's a pivotal bridge between groundbreaking scientific research and the real-world application of life-saving treatments. Here’s why the clinical trial industry is in a league of its own: ✨ Regulatory Environment: The stringent guidelines from entities like the FDA and EMA ensure patient safety and data integrity, making the journey from a lab idea to a market-ready solution both complex and rewarding. 🔍 Ethical Considerations: Balancing the quest for scientific advancement with the paramount importance of participant welfare, this ethical framework influences every aspect of trial design and execution, setting a high bar for accountability and transparency. 🌐 Global Collaboration: Clinical trials are a testament to global cooperation. This level of international collaboration for a common goal—advancing healthcare—is unparalleled. 👥 Patient-Centricity: The industry's shift towards patient-centricity marks a significant departure from traditional models. Today, it's about engaging participants as active partners, respecting their journey, and ensuring their experiences shape future research. The clinical trial industry is more than just another sector. It's the heartbeat of healthcare advancements, a testament to what we can achieve when we unite for a greater cause. #ClinicalTrials #Healthcare #Regulation #PatientCentricity #GlobalHealth
To view or add a comment, sign in
-
VP Enterprise Growth @ Acxiom | Customer Intelligence | Healthcare | Insurance | Investments | CX | Speaker
Strengthening #healthequity is a key driver of better universal health outcomes, and ensuring people have equal access to relevant health information and care is a top priority of many executives in the #healthcare and #lifesciences industries. To support this critical initiative, #marketers must work to battle misinformation, adopt #digital best practices, and ensure the brands they represent have access to the data to uncover #insights to better engage underserved or vulnerable populations. Join us on April 23 to discover how healthcare marketers can play a critical role by using data to accelerate progress in building more equity. There will be an opportunity to ask questions during the live event. #pharma #data #healthdata
Calling all healthcare and pharma marketers! Don't miss this opportunity learn from Acxiom's SVP and Head of Data Products Brady Gadberry and DeepIntent's Founder and CEO Christopher Paquette about how healthcare marketers can use data to help improve universal health outcomes. Sign up for this Worldwide Business Research (WBR) and DigiPharma Connect event: https://lnkd.in/g4wVxpKF
Data's Pivotal Role in Building Health Equity
wbresearch.com
To view or add a comment, sign in